Publications by authors named "Werner Linkesch"

Claim this Profile
V
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Stefan Hatzl, Florian Posch, Arwin Rezai, Maximilian Gornicec, Christine Beham-Schmid, Werner Linkesch

Support Care Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Orhan Sezer, Meral Beksac, Roman Hajek, Gülsan Sucak, Seckin Cagirgan, Werner Linkesch

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Gregor Aschauer, Richard Greil, Werner Linkesch, Thomas Nösslinger, Richard Stauder

Clin Lymphoma Myeloma Leuk· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation.
Laurent Pascal, Luciana Tucunduva, Annalisa Ruggeri, Didier Blaise, Patrice Ceballos, Werner Linkesch

Blood· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.
Ines Wasle, Gabriele Gamerith, Florian Kocher, Patrizia Mondello, Thomas Jaeger, Werner Linkesch

Ann Hematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.
Sabine Cerny-Reiterer, Anja Rabenhorst, Gabriele Stefanzl, Susanne Herndlhofer, Gregor Hoermann, Werner Linkesch

Oncotarget· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis.
Marie Robin, Federica Giannotti, Eric Deconinck, Mohamad Mohty, Mauricette Michallet, Werner Linkesch

Biol Blood Marrow Transplant· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Lisa Pleyer, Sonja Burgstaller, Michael Girschikofsky, Werner Linkesch, Reinhard Stauder

Ann Hematol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
Luciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, Sabine Furst, Jan Cornelissen, Werner Linkesch

Br J Haematol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
Angelika Valentin, Katharina Troppan, Michael Pfeilstöcker, Thomas Nösslinger, Werner Linkesch

Leuk Lymphoma· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Lisa Pleyer, Ulrich Germing, Wolfgang R Sperr, Werner Linkesch, Sonja Burgstaller

Leuk Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Georg Hopfinger, Thomas Nösslinger, Alois Lang, Werner Linkesch, Thomas Melchardt

Ann Hematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Heinz Ludwig, Hedwig Kasparu, Clemens Leitgeb, Elisabeth Rauch, Werner Linkesch

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
Lisa Pleyer, Reinhard Stauder, Sonja Burgstaller, Martin Schreder, Christoph Tinchon, Werner Linkesch

J Hematol Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Marlene Troch, Barbara Kiesewetter, Wolfgang Willenbacher, Ella Willenbacher, Armin Zebisch, Werner Linkesch

Haematologica· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Konstantin Schlick, Ariane Aigelsreiter, Martin Pichler, Sonja Reitter, Peter Neumeister, Werner Linkesch

Onkologie· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
Christian W Scholz, Antonello Pinto, Werner Linkesch, Ola Lindén, Andreas Viardot

J Clin Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Jürgen Finke, Claudia Schmoor, Wolfgang A Bethge, Hellmut D Ottinger, Matthias Stelljes, Werner Linkesch

Biol Blood Marrow Transplant· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
Martin Hoenigl, Volker Strenger, Walter Buzina, Thomas Valentin, Christoph Koidl, Werner Linkesch

J Antimicrob Chemother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.
Peter Valent, Günther Gastl, Klaus Geissler, Richard Greil, Oliver Hantschel, Werner Linkesch

Crit Rev Oncol Hematol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
Martin Hoenigl, Helmut J F Salzer, Reinhard B Raggam, Thomas Valentin, Angelika Rohn, Werner Linkesch

Med Mycol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.
Isabella Fried, Claudia Bodner, Monika M Pichler, Karin Lind, Christine Beham-Schmid, Werner Linkesch

Haematologica· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].
Ingrid Pabinger, Günther Gastl, Michael Steurer, Siegfried Sormann, Michael Fillitz, Werner Linkesch

Wien Klin Wochenschr· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the International Radioimmunotherapy Network.
Karin Hohloch, Angelika Bischof Delaloye, Christiane Windemuth-Kieselbach, Jose Gómez-Codina, Werner Linkesch

J Nucl Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Gérard Socié, Claudia Schmoor, Wolfgang A Bethge, Hellmut D Ottinger, Matthias Stelljes, Werner Linkesch

Blood· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis